Patent ID: 7951365
Filing Date: 2011-05-31
Classification: A61K

Abstract:
1. A method for treating a patient suffering from a neoplastic disease selected from gall bladder cancer, hepato cellular cancer, ovarian cancer, small intestine cancer, lung cancer, mesothelioma, breast cancer, kidney cancer, pancreas cancer, prostate cancer, carcinoid cancer, leiomyosarcoma, or metastasis thereof, the method comprising: a) isolating tumour-reactive T-lymphocytes from either the patient's blood, or from the patient's lymph nodes, wherein tumour-reactive T-lymphocytes isolated from the patient's lymph nodes are obtained by: b) in vitro expanding said tumour-reactive T-lymphocytes isolated from either the patient's blood or lymph nodes using: c) administering the thus obtained tumour-reactive T-lymphocytes to the patient.